Background. Two serologic syphilis screening algorithms recommended by the US Centers for Disease Control and Prevention (US CDC) and the European Centre for Disease Prevention and Control (ECDC), respectively, are commonly used for syphilis screening; however, which one is optimal remains to be determined.
Syphilis poses a great threat to human health worldwide. The majority of syphilis cases occur in underdeveloped countries, particularly in sub-Saharan Africa and Asia [1] . The syphilis epidemic has also occurred among men who have sex with men in European countries and North America [2] . Moreover, about 10 million new infections appear each year [3] . Thus, it has become increasingly important to apply a better strategy to diagnose, treat, and prevent syphilis.
As the causative agent of syphilis, Treponema pallidum is a bacterium that cannot be detected with simple laboratory staining assays. The diagnosis of syphilis primarily relies on serologic tests, as patients naturally infected with T. pallidum are often characterized by periods without clinical manifestations [4] . Two types of serologic tests are used for the diagnosis of syphilis: treponemal and nontreponemal tests. The former includes chemiluminescent immunoassays (CIA), enzyme immunoassays (EIA), and the T. pallidum particle agglutination assay (TPPA), while the latter includes the rapid plasma reagin (RPR) and Venereal Disease Research Laboratory tests. Treponemal tests are primarily used to identify the presence of syphilis infection, whereas nontreponemal tests are largely used to monitor the infection status and treatment response [5] .
Two common algorithms exist for serological diagnosis of syphilis: the traditional and reverse algorithms [6] . In the traditional algorithm, syphilis serologic screening begins with a nontreponemal test, followed by confirmation (if reactive in the nontreponemal test) using 1 of several treponemal tests, such as TPPA [7, 8] . However, this algorithm has several limitations, including lack of specificity, low sensitivity, manual operation, and subjective interpretation of results [9, 10] . To reduce the time and cost required for syphilis screening, more laboratories are adopting a reverse algorithm that begins with a treponemal assay [6, 7, [9] [10] [11] . There are 2 implementation schemes for this reverse algorithm. The first one is recommended by the US Centers for Disease Control and Prevention (US CDC), referred to as the "US CDC-recommended algorithm" hereinafter. This scheme involves an initial reactive treponemal screening assay such as CIA, followed by a quantitative nontreponemal assay such as RPR [9, 12] . If the initial and subsequent test results disagree, the M A J O R A R T I C L E specimen is then tested with a second treponemal test (TPPA) [7] . The second scheme is recommended by the European Centre for Disease Prevention and Control (ECDC), and hereinafter referred to as the "ECDC-recommended algorithm. " It involves a reactive treponemal assay, followed by a second, different treponemal assay as a confirmatory test. If the confirmatory test is reactive, a quantitative nontreponemal assay is used to assess the disease activity and treatment response [13] . However, it remains controversial which implementation scheme of the reverse algorithms is better for the diagnosis of syphilis.
This study evaluated the performances of the US CDC-and ECDC-recommended algorithms in the diagnosis of syphilis, as well as explored the necessity of reviewing clinical records and serological follow-up among subjects with CIA-reactive (CIA + ), RPR-nonreactive (RPR -), TPPA-nonreactive (TPPA -) (isolated CIA reactive) serum. Our ultimate goal was to help in the selection of the optimal syphilis serodiagnostic algorithm and improve the diagnostic efficiency for syphilis.
METHODS

Study Design and Ethics Statement
To evaluate the performances of the US CDC-and ECDCrecommended algorithms in the diagnosis of syphilis, we carried out a prospective study in Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China, from January 2015 to January 2016.
The subjects of this study included outpatients, inpatients, and populations undergoing routine health examinations. They underwent syphilis testing for screening (if asymptomatic), for diagnosis (if symptomatic), or for monitoring the response to syphilis treatment. Patient groups used in the study are summarized in Figure 1 . Subjects were first screened for antibodies against T. pallidum using the Architect syphilis TP assay (a CIA) (Abbott Diagnostics, Abbott Park, Illinois). When determined to be reactive by this assay, the specimens were then tested with TPPA (Fujirebio, Tokyo, Japan) and RPR (KHB, Shanghai, China) ( Figure 2 The analytical sensitivity of TPPA was determined by performing serial dilution of treponemal antibody-containing sera coming from syphilis patients. Each of the dilutions was also measured by the CIA test and given a signal-to-cutoff (S/ CO) ratio. Ethical approval covering the study protocol was obtained from the Human Ethics Committee of Tongji Medical College.
Clinical Diagnosis of Syphilis
According to the International Union Against Sexually Transmitted Infection 2014 guidelines [14] , a sample was considered syphilis positive when both CIA and TPPA were reactive. However, CIA + TPPA − subjects showing prior or subsequent clinical or serological evidence of syphilis were also diagnosed as syphilis positive [14, 15] .
Data Analysis
Statistical analyses were performed using SPSS version 19 for Windows (IBM, Chicago, Illinois). The percentage of agreement and κ coefficient were calculated to determine the agreement between the US CDC-and ECDC-recommended algorithms. The agreement of the results (κ value) was categorized as near perfect (0.81-1.0), substantial (0.61-0.8), moderate (0.41-0.6), fair (0.21-0.4), slight (0-0.2), or poor (<0) [16] .
RESULTS
A Summary of Syphilis Testing Results
A total of 119 891 serum samples were included in this study. , respectively. The positive rate for syphilis determined by the US CDC-and ECDC-recommended algorithms was 1.43% and 1.42%, respectively, indicating a low prevalence of syphilis in this population ( Figure 2 ).
Diagnostic Consistency of the 2 Testing Algorithms
The syphilis diagnostic flow charts using the US CDC-and ECDCrecommended algorithms are illustrated in Figure 2 . The overall percentage of agreement and κ value between the 2 algorithms were 99.996% and 0.999, respectively, indicating a high degree of consistency between these 2 algorithms (Table 1) between these 2 algorithms. These 5 subjects were >60 years old. They were considered as having past or present syphilis according to the US CDC-recommended algorithm, but no syphilis based on the ECDC-recommended algorithm. Among them, 2 patients (patients 1-2) had a documented history and previous serological evidence of syphilis, and 1 patient (patient 4) had subsequent serological evidence of syphilis. The other 2 patients (patients 3 and 5) had high CIA S/CO ratios (12.44 and 34.34). Patient 5 had a documented history of syphilis, while patient 3 could not provide any syphilis-associated information due to health problem. Patients 1, 3, and 5 may have contracted nonactive syphilis, as they showed no clear syphilis-associated syndromes. Also, the RPR titers were low (≤1:4), and/or the changes in RPR titers in these patients between previous/future RPR results did not exceed . Rapid plasma reagin testing was used to monitor the activity of syphilis. Abbreviations: CIA, chemiluminescence immunoassay; RPR, rapid plasma regain test; S/CO, signal-to-cutoff ratio; TP, Treponema pallidum; TPPA, Treponema pallidum particle agglutination assay. ). The instability of CIA and TPPA seen in this subject likely results from low titer of treponemal antibodies. While patients 1-7 showed previous serological evidence of syphilis, patients 8 and 9 had no records of prior serology tests for syphilis and did not report any history of syphilis. Surprisingly, patients 8 and 9 seroconverted to TPPA + serology during the follow-up study.
Overall, a total of 3 CIA + TPPA -RPR -subjects (patients 7-9) seroconverted to TPPA + but remained RPR -. These patients did not develop any signs of syphilis, and their serum samples showed low CIA S/CO ratios (<2), suggesting the presence of low titers of treponemal antibodies in their sera.
DISCUSSION
Our results demonstrated a high consistency between the US CDC-recommended algorithm and the ECDC-recommended algorithm in the serodiagnosis of syphilis in a population with a low prevalence of syphilis (1.40%). Interestingly, the high consistency between these 2 algorithms was also seen in a population with a high prevalence (11.40%) of syphilis [15] . In our study, the US CDC-recommended algorithm detected 5 more syphilis patients than the ECDC-recommended algorithm. Moreover, the US CDC-recommended algorithm is more cost-effective than the ECDC-recommended algorithm (Supplementary Table 1 ). Based on these findings, we propose that the US CDC-and ECDC-recommended algorithms have similar performances, and the US CDC-recommended algorithm has a slight advantage over the ECDC algorithm for syphilis screening in a population with a low prevalence of syphilis. This is different from the study by Tong et al, where the ECDCrecommended algorithm was recommended, although the US CDC-recommended algorithm also detected 18 more syphilis patients in their study. Interestingly, Tong et al did not include a nontreponemal test (eg, RPR) in the ECDC recommended algorithm to assess disease activity when both screening and confirmatory treponemal assays were reactive, which was strongly recommended in the 2014 European guideline on the management of syphilis [14] . Notably, when applying the US CDC-recommended algorithm, the screening treponemal assay (CIA or EIA) should have higher analytical sensitivity than TPPA, which is designated as the sole confirmatory assay [7] . In our study, a CIA (Architect Syphilis TP assay, Abbott Diagnostics) was used as the screening assay, which has been adopted worldwide due to its high sensitivity, full automation, and high throughput capability [17] . Indeed, we found that Architect TP assay had a lower analytical limit than TPPA (Table 2) . In contrast to our study, Tong et al used TPPA as the screening assay and a CIA remains elusive but vital to clinicians [18, 19] . As highlighted by other groups, misclassifying an isolated reactive screening test as positive could lead to false treatment and mental stress, whereas misclassifying an isolated reactive immunoassay as negative could result in a missed diagnosis of early syphilis, infectious syphilis transmission, and the possibility of untreated latent disease [18, 19] . Understanding the reasons behind these discordant results will undoubtedly benefit from population-based laboratory findings. In line with the current US CDC sexually transmitted disease guidelines, 2 US CDC laboratory reviews concluded that syphilis is unlikely if sera are TPPA - [7, 20] .
Other researchers have attempted to assess the significance of cases with an isolated EIA/CIA+ specimen through assessment of individual cases [21, 22] . Woznicová et al [21] studied a Czech sexual health clinic population, and found that a total of 40% (8/20) of cases with an isolated reactive EIA specimen were classified as latent syphilis, 25% (5/20) had passive antibody transfer from their mother, 15% (3/20) had other infections, and the remaining 20% (4/20) showed no overt clinical factors involved. Another study performed in an Australian population [22] also found that 11 of 20 patients (55%) with an isolated reactive [14] . Once a patient has been treated for syphilis, treponemal antibodies are assumed to be detectable for life [23] . However, recent studies suggest that this may not be always the case. For instance, treponemal antibody seroreversion is documented in up to 24% of syphilis cases diagnosed by traditional treponemal tests [24] . In line with the seroreversion hypothesis, we identified 7 subjects who were CIA We also observed complete seroreversion (including seroreversion of the syphilis CIA) in 2 infants of syphilis patients. Obviously, the discovery rate of discordant results between screening and confirmatory assays depends on the prevalence of syphilis [25] and the performance of the detection system. Altogether, our results strongly suggest that detailed medical and serological analysis should be performed for subjects with conflicting screening and confirmatory test results. While our data will be instrumental for the diagnosis of syphilis, there are a few limitations in our study. For instance, some patients may have used false information (name and age) to protect their privacy, making it impossible to determine their syphilis infection and treatment history. Also, some patients either denied or responded that they were unaware of their infection status. In this case, however, we were able to review the clinical records and confirm some syphilis cases through a documented history of syphilis and/or previous or subsequent serological evidence of syphilis infection, making our conclusions more reliable. Another potential variable in our study is that we assessed the algorithms in a population with low prevalence of syphilis, suggesting that the positive predictive values could be relatively low. This also means that the same algorithms may work slightly different in populations with high prevalence of syphilis, although it merits further investigations.
Overall, our data strongly argue for the idea that the US CDC-and ECDC-recommended algorithms have a high consistency in the serodiagnosis of syphilis in low-prevalence populations. Additionally, for cases with an isolated reactive screening test, detailed clinical and serological assessment is warranted to reduce the diagnostic miss rate for syphilis. 
